成AV免费大片黄在线观看 ,天堂中文8资源在线8,欧美三级在线播放,国内精品久久久久影视

<pre id="5iarw"></pre><rp id="5iarw"></rp>

<p id="5iarw"></p>

NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing

Another quick approval

2025-05-22

Learn more +
Paclitaxel For Injection (Albumin Bound) approved by US FDA

2025-05-20

Learn more +
King-Friend will meet you in CPHI Frankfurt!

Explore the infinite boundaries of the pharmaceutical market！

2025-05-19

Learn more +
King-Friend will meet you in CPHI Shanghai!

Explore the infinite possibilities of the pharmaceutical industry！

2025-05-13

Learn more +
NKF's Liraglutide Injection gets FDA approval for marketing

Benefiting more patients around the world.

2025-04-04

Learn more +
NKF's Rocuronium Bromide Injection getting approved by NMPA

Bring new hope for health to thousands of patients.

2025-03-01

Learn more +
NKF's Fulvestrant Injection getting approved by NMPA

Help to enhance treatment experience and health well-being.

2025-02-11

Learn more +
NKF's Methylene Blue Injection gets FDA approval for marketing

Let every medication be a solemn commitment to life.

2025-01-25

Learn more +
NKF's Cyanocobalamin Injection gets FDA approval for marketing

Help patients regain their body balance and health vitality.

2024-11-19

Learn more +

1
2

Stock price

11.070

-0.2

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd蘇ICP備13012010號(hào)